Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
NASDAQ | TSX:ACB
EDMONTON, AB, Feb. 8, 2024 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX:ACB), the Canada-based leading global medical cannabis company, today announced its financial and operational results for the third quarter of fiscal year 2024. As the fiscal year 2023 consisted of three quarters, the year-over-year comparison quarter for Q3 2024 ending December 31, 2023, is Q2 2023 ending December 31, 2022.
Related news for (ACB)
- MoBot’s Stock Market Highlights – 08/11/25 06:00 PM
- Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting
- Aurora Cannabis Announces Fiscal 2026 First Quarter Results
- Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting of Shareholders
- Aurora Cannabis to Host First Quarter 2026 Investor Conference Call